Erin R. Gardner
- Molecular Biology top 5%
- Oncology top 2%
- Hematology top 5%
- Pathology and Forensic Medicine top 5%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- William D. FiggSusan E. BatesRichard PiekarzWilliam L. DahutRobin FryeAlex SparreboomSeth M. SteinbergRobert W. Robey
- Topics
- Cancer Treatment and Pharmacology (9 papers)Histone Deacetylase Inhibitors Research (8 papers)Multiple Myeloma Research and Treatments (7 papers)
- Cited by
- OncologyHematologyDermatology
- Partner nations
- United StatesTaiwanUnited Kingdom
In The Last Decade
Erin R. Gardner
48 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Biology 1.5k
- Oncology 1.1k
- Hematology 324
- Pathology and Forensic Medicine 281
- Pulmonary and Respiratory Medicine 256
Countries citing papers authored by Erin R. Gardner
This map shows the geographic impact of Erin R. Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin R. Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin R. Gardner more than expected).
Fields of papers citing papers by Erin R. Gardner
This network shows the impact of papers produced by Erin R. Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin R. Gardner. The network helps show where Erin R. Gardner may publish in the future.
Co-authorship network of co-authors of Erin R. Gardner
This figure shows the co-authorship network connecting the top 25 collaborators of Erin R. Gardner. A scholar is included among the top collaborators of Erin R. Gardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin R. Gardner. Erin R. Gardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 108 | |
| 3 | 1 | |
| 4 | 24 | |
| 5 | 151 | |
| 6 | 29 | |
| 7 | 4 | |
| 8 | 224 | |
| 9 | 181 | |
| 10 | 22 | |
| 11 | 21 | |
| 12 | 8 | |
| 13 | Pharmacokinetic and biomarker analysis in a phase II trial of the HDAC inhibitor romidepsin, FK228 | 1 |
| 14 | 6 | |
| 15 | 13 | |
| 16 | 42 | |
| 17 | 264 | |
| 18 | 57 | |
| 19 | 107 | |
| 20 | 38 |
About Erin R. Gardner
Erin R. Gardner is a scholar working on Hematology, Oncology and Pharmacology, having authored 49 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Histone Deacetylase Inhibitors Research (8 papers) and Multiple Myeloma Research and Treatments (7 papers). The work is most often cited by research in Oncology (1.1k citations), Hematology (324 citations) and Dermatology (232 citations). Erin R. Gardner has collaborated with scholars based in United States, Taiwan and United Kingdom. Frequent co-authors include William D. Figg, Susan E. Bates, Richard Piekarz, William L. Dahut, Robin Frye, William D. Figg, Alex Sparreboom, Seth M. Steinberg, Robert W. Robey and Neil Vargesson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.